ASTH
Price
$23.02
Change
+$0.20 (+0.88%)
Updated
Dec 3 closing price
Capitalization
1.15B
77 days until earnings call
Intraday BUY SELL Signals
ENSG
Price
$178.99
Change
-$2.16 (-1.19%)
Updated
Dec 3 closing price
Capitalization
10.37B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs ENSG

Header iconASTH vs ENSG Comparison
Open Charts ASTH vs ENSGBanner chart's image
Astrana Health
Price$23.02
Change+$0.20 (+0.88%)
Volume$368.22K
Capitalization1.15B
Ensign Group (The)
Price$178.99
Change-$2.16 (-1.19%)
Volume$395.82K
Capitalization10.37B
ASTH vs ENSG Comparison Chart in %
ASTH
Daily Signal:
Gain/Loss:
ENSG
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASTH vs. ENSG commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and ENSG is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ASTH: $22.82 vs. ENSG: $181.15)
Brand notoriety: ASTH and ENSG are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 51% vs. ENSG: 21%
Market capitalization -- ASTH: $1.15B vs. ENSG: $10.37B
ASTH [@Hospital/Nursing Management] is valued at $1.15B. ENSG’s [@Hospital/Nursing Management] market capitalization is $10.37B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $111.08B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileENSG’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • ENSG’s FA Score: 1 green, 4 red.
According to our system of comparison, ENSG is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 5 TA indicator(s) are bullish while ENSG’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 5 bullish, 6 bearish.
  • ENSG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ENSG is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -1.72% price change this week, while ENSG (@Hospital/Nursing Management) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -1.31%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 19, 2026.

ENSG is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-1.31% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENSG($10.4B) has a higher market cap than ASTH($1.16B). ASTH has higher P/E ratio than ENSG: ASTH (121.16) vs ENSG (32.02). ENSG YTD gains are higher at: 36.518 vs. ASTH (-27.624). ENSG has higher annual earnings (EBITDA): 526M vs. ASTH (112M). ASTH has less debt than ENSG: ASTH (448M) vs ENSG (2.04B). ENSG has higher revenues than ASTH: ENSG (4.62B) vs ASTH (2.42B).
ASTHENSGASTH / ENSG
Capitalization1.16B10.4B11%
EBITDA112M526M21%
Gain YTD-27.62436.518-76%
P/E Ratio121.1632.02378%
Revenue2.42B4.62B52%
Total Cash342MN/A-
Total Debt448M2.04B22%
FUNDAMENTALS RATINGS
ASTH vs ENSG: Fundamental Ratings
ASTH
ENSG
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
938
SMR RATING
1..100
8749
PRICE GROWTH RATING
1..100
8946
P/E GROWTH RATING
1..100
448
SEASONALITY SCORE
1..100
2635

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSG's Valuation (72) in the Medical Or Nursing Services industry is in the same range as ASTH (84) in the null industry. This means that ENSG’s stock grew similarly to ASTH’s over the last 12 months.

ENSG's Profit vs Risk Rating (8) in the Medical Or Nursing Services industry is significantly better than the same rating for ASTH (93) in the null industry. This means that ENSG’s stock grew significantly faster than ASTH’s over the last 12 months.

ENSG's SMR Rating (49) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (87) in the null industry. This means that ENSG’s stock grew somewhat faster than ASTH’s over the last 12 months.

ENSG's Price Growth Rating (46) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (89) in the null industry. This means that ENSG’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's P/E Growth Rating (4) in the null industry is somewhat better than the same rating for ENSG (48) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew somewhat faster than ENSG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHENSG
RSI
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
54%
Momentum
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
71%
MACD
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
61%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 14 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 7 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
87%
Bearish Trend 7 days ago
53%
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bullish Trend 7 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
ENSG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLCTX13.13N/A
N/A
Wilshire International Equity Invmt
MEIFX13.89N/A
N/A
Meridian Hedged Equity Legacy
TGCEX33.94N/A
N/A
TCW Concentrated Large Cap Growth I Cl
BIERX28.14N/A
N/A
Brandes International Equity R6
FZEMX49.26N/A
N/A
Fidelity Advisor Emerging Markets Z

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-1.55%
ACHC - ASTH
50%
Loosely correlated
-2.08%
DCGO - ASTH
40%
Loosely correlated
-0.65%
UHS - ASTH
32%
Poorly correlated
-0.34%
PNTG - ASTH
32%
Poorly correlated
+3.17%
ENSG - ASTH
30%
Poorly correlated
-1.35%
More

ENSG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSG has been loosely correlated with UHS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSG jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSG
1D Price
Change %
ENSG100%
-1.35%
UHS - ENSG
59%
Loosely correlated
-0.34%
HCA - ENSG
54%
Loosely correlated
-0.54%
EHC - ENSG
52%
Loosely correlated
-0.75%
PNTG - ENSG
51%
Loosely correlated
+3.17%
THC - ENSG
49%
Loosely correlated
-0.08%
More